Christopher Bowden
2015
In 2015, Christopher Bowden earned a total compensation of $2.3M as Chief Medical Officer at Agios Pharmaceuticals, a 33% decrease compared to previous year.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $153,439 |
| Option Awards | $1,164,002 |
| Salary | $403,800 |
| Stock Awards | $403,717 |
| Other | $10,044 |
| Total | $2,285,002 |
Bowden received $1.2M in option awards, accounting for 51% of the total pay in 2015.
Bowden also received $150K in bonus, $153.4K in non-equity incentive plan, $403.8K in salary, $403.7K in stock awards and $10K in other compensation.
Rankings
In 2015, Christopher Bowden's compensation ranked 4,213th out of 13,638 executives tracked by ExecPay. In other words, Bowden earned more than 69.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,213 out of 13,638 | 69th |
Division Manufacturing | 1,543 out of 5,190 | 70th |
Major group Chemicals And Allied Products | 562 out of 1,854 | 70th |
Industry group Drugs | 445 out of 1,528 | 71st |
Industry Pharmaceutical Preparations | 350 out of 1,182 | 70th |
Source: SEC filing on April 18, 2018.
Bowden's colleagues
We found four more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2015.
News
Agios Pharmaceuticals CEO Jacqualyn Fouse's 2021 pay slips 14% to $6.5M
April 28, 2022
Agios Pharmaceuticals CEO Jacqualyn Fouse's 2020 pay falls 54% to $7.6M
April 8, 2021
Agios Pharmaceuticals CEO Jacqualyn Fouse receives $17M in 2019
April 16, 2020
Agios Pharmaceuticals CEO David Schenkein's 2018 pay jumps 37% to $8.2M
April 18, 2019